v3.26.1
SEGMENT INFORMATION - Segment Revenues and Profit (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment reporting information    
Revenues $ 1,244 $ 1,137
Selling, general and administrative 544 563
Research and development 101 86
Operating income (loss) 33 (83)
Amortization of intangible assets (57) (67)
Other expense, net (26) (22)
Interest income 4 3
Interest expense (97) (94)
Loss on extinguishment of debt (1) 0
Foreign exchange and other (3) (6)
Loss before provision for income taxes (64) (180)
Vision Care    
Segment reporting information    
Revenues 711 656
Pharmaceuticals    
Segment reporting information    
Revenues 305 267
Surgical    
Segment reporting information    
Revenues 228 214
Product sales    
Segment reporting information    
Revenues 1,239 1,133
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 482 481
Other revenues    
Segment reporting information    
Revenues 5 4
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 1
Operating Segment    
Segment reporting information    
Revenues 1,244 1,137
Operating income (loss) 277 180
Operating Segment | Vision Care    
Segment reporting information    
Revenues 711 656
Selling, general and administrative 228 221
Research and development 10 8
Operating income (loss) 202 176
Operating Segment | Pharmaceuticals    
Segment reporting information    
Revenues 305 267
Selling, general and administrative 138 153
Research and development 22 9
Operating income (loss) 66 11
Operating Segment | Surgical    
Segment reporting information    
Revenues 228 214
Selling, general and administrative 73 73
Research and development 13 11
Operating income (loss) 9 (7)
Operating Segment | Product sales    
Segment reporting information    
Revenues 1,239 1,133
Operating Segment | Product sales | Vision Care    
Segment reporting information    
Revenues 708 654
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 271 251
Operating Segment | Product sales | Pharmaceuticals    
Segment reporting information    
Revenues 304 266
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 78 93
Operating Segment | Product sales | Surgical    
Segment reporting information    
Revenues 227 213
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 133 137
Operating Segment | Other revenues    
Segment reporting information    
Revenues 5 4
Operating Segment | Other revenues | Vision Care    
Segment reporting information    
Revenues 3 2
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0
Operating Segment | Other revenues | Pharmaceuticals    
Segment reporting information    
Revenues 1 1
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 1 1
Operating Segment | Other revenues | Surgical    
Segment reporting information    
Revenues 1 1
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 0 0
Corporate    
Segment reporting information    
Operating income (loss) $ (161) $ (174)